An Epidemiological Study of Anemia and Renal Dysfunction in Patients Admitted to ICUs across the United States

Table 5

Odds ratios for mortality based on eGFR, ESA, and PRBC treatment.

	Unadjusted data		Adjusted data*
	OR (95% CI)	P	OR (95% CI)	P
eGFR (mL/min/1.73 m^2)
Dialysis	1.4 (0.87–2.20)	0.164	1.94 (1.22–3.08)	0.005
<30	3.1 (2.46–3.89)	<0.001	2.66 (2.05–3.45)	<0.001
30–59	1.6 (1.37–1.92)	<0.001	1.40 (1.20–1.66)	<0.001
≥60	—	—	—	—
ESA treatment	1.1 (0.79–1.53)	0.587	0.86 (0.43 –1.72)	0.674
PRBC treatment	0.91 (0.67–1.25)	0.571	1.10 (0.82 –1.38)	0.641

* Adjusted for age, race, sex, ICU LOS, ESA use, transfusion status, mechanical ventilation or CPAP status, vasopressor use, severity of, illness, and presence of, following comorbid conditions, GI bleed, sepsis, and neurologic injury.